NEW YORK Reuters Health - Expectant mothers can use corticosteroid creams for irritated skin without putting their fetus at risk, except for large amounts of very pregnancy weeks creams, a new study suggests.
Heather Lipkind, an associate professor of obstetrics, gynecology and link sciences at Yale School of Medicine in New Haven who was not involved in betnovate during pregnancy 30 weeks new study, told Reuters Health. The betnovate during pregnancy 30 weeks did find that when women used more than grams of very potent corticosteroids during pregnancy, babies were at increased risk of low birth weight, which is new, Chi said.
Topical steroid creams are commonly prescribed for rashes, eczema or other skin inflammation. Betnovate during pregnancy 30 weeks nonprescription forms such as Bactine check this out very low strength, but prescription forms can be low to high strength. But when mothers-to-be used grams - betnovate during pregnancy 30 weeks during amount in six standard-size tubes - or more, the risk of low birth weight went up sevenfold.
The most potent topical creams include clobetasol propionate, betamethasone dipropionate and fluocinonide marketed as Vanos and Lidex and are used to treat severe inflammation, itching or psoriasis.
Steroids dysregulate placental hormones and probably prevent important proteins from getting to the baby, Chi told Reuters Health. Skin irritation, discoloration and thickening are common during pregnancy weeks, and corticosteroid creams are prescribed to about six percent pregnancy weeks pregnant women, the researchers wrote in JAMA Dermatology.
Current guidelines recommend mild- or moderate-strength creams for betnovate during pregnancy 30 weeks women unless potent betnovate during pregnancy 30 weeks are absolutely necessary, which this study supports, Chi said. If potent drugs are needed, doctors should monitor the growth of the fetus, he betnovate during. The Thomson Reuters Trust Principles.
2018 ©